Pharma’s development races are heating up

The drug business can feel like a go-kart race, with big pharmaceutical giants and biotech startups knocking against each other as they scramble to be the first to market with the next big blockbuster.

Plenty of hot drug development races are on this summer. Companies are striving to be the first to market with next-generation therapies for diseases as common as rheumatoid arthritis, or as rare as spinal muscular atrophy…